Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2015

Sep 24, 2015

32414_dirs_2015-09-24_9c26dd6e-0a49-44f9-9d0c-06693d3db291.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-09-22

Reporting Person: Donovan Michael Patrick (Vice President, Operations)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-09-22 Employee Stock Option (right to buy) $5.14 A 25000 Acquired 2022-09-22 Common Stock (25000) Direct

Footnotes

F1: All shares pursuant to the employee stock option will be fully vested on September 22, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on September 22, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.